Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand
of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Certican
Active Ingredient: Everolimus 0.25mg
Dosage Form: Tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Pharma AG, Basel, Switzerland
Novartis Pharma Stein AG, Stein, Switzerland
Product: Certican
Active Ingredient: Everolimus 0.50mg
Dosage Form: Tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Pharma AG, Basel, Switzerland
Novartis Pharma Stein AG, Stein, Switzerland
Product: Certican
Active Ingredient: Everolimus 0.75mg
Dosage Form: Tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Pharma AG, Basel, Switzerland
Novartis Pharma Stein AG, Stein, Switzerland
Product: Certican
Active Ingredient: Everolimus 1mg
Dosage Form: Tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Pharma AG, Basel, Switzerland
Novartis Pharma Stein AG, Stein, Switzerland
Product: Certican
Active Ingredient: Everolimus 0.10mg
Dosage Form: Dispersible tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Pharma AG, Basel, Switzerland
Novartis Pharma Stein AG, Stein, Switzerland
Product: Certican
Active Ingredient: Everolimus 0.25mg
Dosage Form: Dispersible tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Pharma AG, Basel, Switzerland
Novartis Pharma Stein AG, Stein, Switzerland
Dated this 22nd day of May 2014.
SUSAN MARTINDALE, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister
of Health on 11 September 2013).